Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Silverstone

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Psychiatry|December 17, 2004
Qualitative review of SNRIs in anxietyPeter H Silverstone
Journal of Clinical Psychopharmacology|February 24, 1998
Prevention of clozapine-induced neutropenia by pretreatment with lithiumP H Silverstone
Journal of Psychosomatic Research|August 1, 1996
Concise assessment for depression (CAD): a brief screening approach to depression in the medically illP H Silverstone
Acta Psychiatrica Scandinavica|April 1, 1991
Is anhedonia a good measure of depression?P H Silverstone
The Journal of Clinical Psychiatry|August 8, 2001
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorderP H Silverstone, E Salinas
The Journal of Clinical Psychiatry|March 13, 1999
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study GroupP H Silverstone, A Ravindran
Public Health|November 1, 1975
A clinical study of skin cancer: genetic and environmental interactionsB A Smithurst, H Silverstone
Mental Illness|December 6, 2014
Off-label use of atomoxetine in adults: is it safe?Rana Dadashova, Peter H Silverstone
Annals of General Hospital Psychiatry|March 7, 2003
Low self-esteem and psychiatric patients: Part I - The relationship between low self-esteem and psychiatric diagnosisPeter H Silverstone, Mahnaz Salsali
Annals of General Psychiatry|March 13, 2012
Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokersPeter H Silverstone, Rana Dadashova
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Psychiatry|December 17, 2004
Qualitative review of SNRIs in anxietyPeter H Silverstone
Journal of Clinical Psychopharmacology|February 24, 1998
Prevention of clozapine-induced neutropenia by pretreatment with lithiumP H Silverstone
Journal of Psychosomatic Research|August 1, 1996
Concise assessment for depression (CAD): a brief screening approach to depression in the medically illP H Silverstone
Acta Psychiatrica Scandinavica|April 1, 1991
Is anhedonia a good measure of depression?P H Silverstone
The Journal of Clinical Psychiatry|August 8, 2001
Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorderP H Silverstone, E Salinas
The Journal of Clinical Psychiatry|March 13, 1999
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study GroupP H Silverstone, A Ravindran
Public Health|November 1, 1975
A clinical study of skin cancer: genetic and environmental interactionsB A Smithurst, H Silverstone
Mental Illness|December 6, 2014
Off-label use of atomoxetine in adults: is it safe?Rana Dadashova, Peter H Silverstone
Annals of General Hospital Psychiatry|March 7, 2003
Low self-esteem and psychiatric patients: Part I - The relationship between low self-esteem and psychiatric diagnosisPeter H Silverstone, Mahnaz Salsali
Annals of General Psychiatry|March 13, 2012
Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokersPeter H Silverstone, Rana Dadashova
Pageof 14